Cargando…
Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis
BACKGROUND: TAS-102 has been applied to metastatic colorectal cancer (mCRC) patients who had received at least two prior regimens of standard chemotherapy. This meta-analysis is designed to assess the efficacy and safety of TAS-102 in patients with mCRC. METHODS: We searched randomized controlled tr...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118256/ https://www.ncbi.nlm.nih.gov/pubmed/30214286 http://dx.doi.org/10.2147/CMAR.S174584 |